Explainer: Anti Alzheimer’s, Dravet Syndrome, Epilepsy & Addiction Drugs – The Daily Dive

On today’s Daily Dive, Cassandra welcomes back Ian McDonald, CEO of Bright Minds Biosciences (CSE: DRUG). He shares the promising results of the company’s proprietary BMB-101 drug to treat a rare form of epilepsy, Dravet Syndrome. The chief officer also talks about the firm’s plan to list on the Nasdaq, the common misconceptions on psychedelics, and the overall outlook of the biotech company in the medical space.

Bright Minds is focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain. Bright Minds has a portfolio of next generation serotonin agonists designed to precisely target abnormalities in neurocircuitry that lead to dysfunctional behaviors. The company is developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders through the use of serotonergic compounds leveraging its world class scientific and drug development expertise to bring forward the next generation of safe and efficacious drugs.


FULL DISCLOSURE: Bright Minds Biosciences is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Bright Minds Biosciences on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Hemlo Explorers: Amassing The Largest Land Package In The Hemlo Region – The Daily Dive

Today on the Daily Dive we are joined by first time guest Brian Howlett, CEO...

Thursday, April 14, 2022, 01:30:00 PM

US Cannabis: How Will New York Play Out? – The Daily Dive Featuring Bruce Linton

Joining back on the Daily Dive is Bruce Linton, founder and former CEO of Canopy...

Tuesday, September 28, 2021, 01:30:00 PM

Gold’s Place in a Digital World: How Can We Make Mining Sexy Again? | Kai Hoffmann

In this interview, Kai Hoffmann of Soar Financial provides insight into the evolving junior mining...

Saturday, December 14, 2024, 09:33:00 AM

Gold Transactions Heating Up – The Daily Dive feat John-Mark Staude of Riverside Resources

Today on The Daily Dive, we are joined by our bi-weekly commentator John-Mark Staude, CEO...

Tuesday, January 5, 2021, 01:30:00 PM

Potash & Lithium: American Potash’s Double Play | Simon Clarke

In this interview, Simon Clarke, President & CEO of American Potash Corp. (CSE:KCL, OTC PINK:...

Friday, October 18, 2024, 10:05:00 AM